Quest Diagnostics Incorporated is a prominent provider of extensive diagnostic information services operating throughout the United States and in international territories The company specializes in developing and delivering a broad spectrum of diagnostic insights including standard routine tests highly specialized and advanced clinical analyses anatomical pathology examinations and other crucial diagnostic information services These services are primarily offered under the flagship Quest Diagnostics brand supplemented by specialized brands such as AmeriPath Dermpath Diagnostics ExamOne and Quanum The company caters to a diverse array of clients including individual patients medical professionals hospitals independent delivery networks health plans employers direct contract entities and accountable care organizations Service delivery is facilitated through a vast integrated network comprising laboratories dedicated patient service centers onsite phlebotomists within physician offices call centers for remote support and mobile healthcare professionals like paramedics and nurses Beyond its core diagnostic offerings Quest Diagnostics also extends its expertise to provide risk assessment services tailored for the life insurance industry and it equips healthcare organizations and clinicians with robust information technology solutions Established in 1967 Quest Diagnostics Incorporated maintains its corporate headquarters in Secaucus New Jersey
Recent Earnings Surprises
Date
Actual EPS
Estimated EPS
Surprise
2026-04-21
$2.50
$2.37
+5.5%
2026-02-10
$2.42
$2.36
+2.5%
2025-07-22
$2.62
$2.57
+1.9%
2025-04-22
$1.94
$2.15
-9.8%
Financial Ratios (TTM)
Gross Margin
32.91%
Operating Margin
14.39%
Net Margin
9.08%
ROA
6.14%
Price to Book
3.04
Price to Sales
2.00
We value your privacy
We use cookies to analyze traffic and show ads. Accept all cookies, or continue with only the essential ones. Learn more